Suspecting infringement of patents for its Parkinson’s drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.
Private equity firm Goldstone has lost its bid to disqualify a judge from a damages hearing after he found it liable for shareholder oppression of its managing director.
The funder of a class action over the Morrison government’s Robodebt scheme will seek a 15 per cent commission at an upcoming settlement approval hearing, a court has heard, after the case settled for a record $548.5 million.
Refusing to sit out a criminal trial against Boral Cement, a judge has said his sentencing of an engineering firm that pleaded guilty in the SafeWork NSW case did not disqualify him.
The administrators of struggling regional airline Rex have entered into a sale agreement with NASDAQ-listed aviation holding company Air T, with the federal government stepping in to facilitate the sale.
Blooms the Chemist can’t overturn a decision from the Pharmacy Council of NSW blocking the registration of a chemist, with a judge finding there was no evidence Blooms would not have a financial interest in the business.
Ashurst has lured a senior tax partner from MinterEllison, a day after Corrs Chambers announced it has poached the global co-head of Ashurst’s tax practice.
Agricultural giant Graincorp has reached a settlement in a class action by rural Victorians over noise and odour pollution allegedly emitted by its oilseed factory in rural Victoria.
Corrs Chambers Westgarth has added another impressive lateral to its growing tax practice, luring Ashurst’s global co-head of tax.
Abbey Animal Health has appealed its loss in a suit seeking to invalidate rival Virbac’s patent for an antiparasitic drug.